• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

出血性肝细胞腺瘤:历史系列和结果。

Bleeding hepatocellular adenoma: historical series and outcomes.

机构信息

- Santa Casa de Misericórdia, Serviço de Cirurgia Hepatobiliopancreática e Transplante Hepático - Porto Alegre - RS - Brasil.

出版信息

Rev Col Bras Cir. 2023 Jul 10;50:e20233549. doi: 10.1590/0100-6991e-20233549-en. eCollection 2023.

DOI:10.1590/0100-6991e-20233549-en
PMID:37436285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10508653/
Abstract

INTRODUCTION

hepatocellular adenoma - AHC - is a rare benign neoplasm of the liver more prevalent in women at reproductive age and its main complication is hemorrhage. In the literature, case series addressing this complication are limited.

METHODS

between 2010 and 2022, 12 cases of bleeding AHC were attended in a high-complexity university hospital in southern Brazil, whose medical records were retrospectively evaluated.

RESULTS

all patients were female, with a mean age of 32 years and a BMI of 33kg/m2. The use of oral contraceptives was identified in half of the sample and also half of the patients had a single lesion. The mean diameter of the largest lesion was 9.60cm and the largest lesion was responsible for bleeding in all cases. The presence of hemoperitoneum was documented in 33% of the patients and their age was significantly higher than the patients who did not have hemoperitoneum - 38 vs 30 years, respectively. Surgical resection of the bleeding lesion was performed in 50% of the patients and the median number of days between bleeding and resection was 27 days. In only one case, embolization was used. The relation between ingrowth of the lesions and the time, in months, was not obtained in this study.

CONCLUSION

it is concluded that the bleeding AHC of the present series shows epidemiological agreement with the literature and may suggest that older patients trend to have hemoperitoneum more frequently, a fact that should be investigated in further studies.

摘要

介绍

肝细胞腺瘤(AHC)是一种罕见的肝脏良性肿瘤,多见于育龄期妇女,其主要并发症是出血。在文献中,针对这种并发症的病例系列研究有限。

方法

2010 年至 2022 年,在巴西南部一家高复杂度的大学医院共收治了 12 例出血性 AHC 患者,对其病历进行了回顾性评估。

结果

所有患者均为女性,平均年龄 32 岁,BMI 为 33kg/m2。有一半的患者使用了口服避孕药,有一半的患者只有一个病灶。最大病灶的平均直径为 9.60cm,所有病例均由最大病灶引起出血。有 33%的患者存在血腹,且其年龄明显高于无血腹的患者(分别为 38 岁和 30 岁)。有 50%的出血性病变患者接受了手术切除,出血至切除的中位时间为 27 天。仅 1 例患者采用了栓塞治疗。本研究未获得病变生长与时间(以月为单位)之间的关系。

结论

本研究系列中的出血性 AHC 与文献中的流行病学特征一致,可能表明年龄较大的患者更常发生血腹,这一事实有待进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4533/10508653/c688f138724f/rcbc-50-e20233549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4533/10508653/c688f138724f/rcbc-50-e20233549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4533/10508653/c688f138724f/rcbc-50-e20233549-g001.jpg

相似文献

1
Bleeding hepatocellular adenoma: historical series and outcomes.出血性肝细胞腺瘤:历史系列和结果。
Rev Col Bras Cir. 2023 Jul 10;50:e20233549. doi: 10.1590/0100-6991e-20233549-en. eCollection 2023.
2
[Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].[长期使用口服避孕药患者肝腺瘤转变为肝细胞癌]
Rev Hosp Clin Fac Med Sao Paulo. 1994 Jan-Feb;49(1):30-3.
3
Management and outcome of hepatocellular adenoma with massive bleeding at presentation.呈现大量出血的肝细胞腺瘤的管理与结局
World J Gastroenterol. 2017 Jul 7;23(25):4579-4586. doi: 10.3748/wjg.v23.i25.4579.
4
[A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].[一种可能与口服避孕药使用有关的罕见肝脏良性肿瘤:局灶性带蒂结节性增生]
Rev Fr Gynecol Obstet. 1985 Aug-Sep;80(8-9):621-7.
5
Retrospective study on timing of resection of hepatocellular adenoma.回顾性研究肝细胞腺瘤切除术的时机。
Br J Surg. 2017 Nov;104(12):1695-1703. doi: 10.1002/bjs.10594. Epub 2017 Aug 30.
6
Risk factors for bleeding in hepatocellular adenoma.肝细胞腺瘤出血的风险因素。
Br J Surg. 2014 Jun;101(7):847-55. doi: 10.1002/bjs.9493. Epub 2014 Apr 24.
7
Robotic Left Hepatectomy for Hemorrhagic Hepatocellular Adenoma: The Role of Robotic Surgery in a Semi-Acute Setting.机器人辅助左半肝切除术治疗出血性肝细胞腺瘤:机器人手术在亚急性期的作用。
Am Surg. 2023 Nov;89(11):5030-5031. doi: 10.1177/00031348231189830. Epub 2023 Jul 25.
8
A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male.一名非肝硬化男性肝细胞腺瘤内发生肝细胞癌的病例。
Korean J Intern Med. 2009 Jun;24(2):147-52. doi: 10.3904/kjim.2009.24.2.147. Epub 2009 Jun 8.
9
Malignant transformation of hepatocellular adenoma: report of a case.肝细胞腺瘤的恶性转化:一例报告
Pan Afr Med J. 2020 Mar 26;35:92. doi: 10.11604/pamj.2020.35.92.17416. eCollection 2020.
10
Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study.经活检证实患有肝细胞腺瘤的男性发生肝细胞癌的风险很高:一项全国范围内基于人群的研究。
Liver Int. 2017 Jul;37(7):1042-1046. doi: 10.1111/liv.13423. Epub 2017 Apr 11.

本文引用的文献

1
Risk factors for bleeding hepatocellular adenoma in a United States cohort.美国队列中出血性肝细胞腺瘤的危险因素。
Liver Int. 2022 Jan;42(1):224-232. doi: 10.1111/liv.15087. Epub 2021 Nov 12.
2
Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.肝细胞腺瘤出血的危险因素:大小并非唯一关注点!:261 例患者的单中心回顾性经验。
Ann Surg. 2021 Nov 1;274(5):843-850. doi: 10.1097/SLA.0000000000005108.
3
Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery.
肝细胞腺瘤出血:一种可以通过保守治疗而无需手术的并发症。
HPB (Oxford). 2018 Dec;20(12):1198-1205. doi: 10.1016/j.hpb.2018.06.1796. Epub 2018 Jul 7.
4
Management and outcome of hepatocellular adenoma with massive bleeding at presentation.呈现大量出血的肝细胞腺瘤的管理与结局
World J Gastroenterol. 2017 Jul 7;23(25):4579-4586. doi: 10.3748/wjg.v23.i25.4579.
5
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.肝细胞腺瘤的分子分类与危险因素、出血和恶性转化相关。
Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.
6
European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.欧洲573例肝细胞腺瘤肝切除术的经验:AFC-HCA-2013研究组的横断面研究
HPB (Oxford). 2016 Sep;18(9):748-55. doi: 10.1016/j.hpb.2016.06.011. Epub 2016 Jul 22.
7
EASL Clinical Practice Guidelines on the management of benign liver tumours.欧洲肝脏研究学会关于良性肝肿瘤管理的临床实践指南。
J Hepatol. 2016 Aug;65(2):386-98. doi: 10.1016/j.jhep.2016.04.001. Epub 2016 Apr 13.
8
Outcomes of liver resection for haemorrhagic hepatocellular adenoma.出血性肝细胞腺瘤肝切除的结果
Int J Surg. 2016 Mar;27:34-38. doi: 10.1016/j.ijsu.2016.01.041. Epub 2016 Jan 22.
9
Management of bleeding liver tumors.肝肿瘤出血的管理
J Visc Surg. 2014 Oct;151(5):365-75. doi: 10.1016/j.jviscsurg.2014.05.007. Epub 2014 Jun 18.
10
Risk factors for bleeding in hepatocellular adenoma.肝细胞腺瘤出血的风险因素。
Br J Surg. 2014 Jun;101(7):847-55. doi: 10.1002/bjs.9493. Epub 2014 Apr 24.